中性粒细胞胞外诱捕网在白塞病患者中的关键作用
该研究评估中性粒细胞胞外诱捕网(NETs)及标志物在白塞病(BD)中的作用,发现活动期BD患者血清cfDNA和MPO-DNA复合物升高,且血管受累者更高;BD血浆凝血酶生成增加并与NETs标志物正相关,DNAse处理可显著降低BD血浆凝血酶生成,提示NETs促进促凝状态。
要点
- 活动期BD患者血清cfDNA和MPO-DNA复合物较非活动期和健康对照升高。
- BD伴血管受累者cfDNA和MPO-DNA复合物水平显著高于无血管症状者。
- BD血浆凝血酶生成增加且与NETs标志物正相关,DNAse处理可降低。
核心结论
- NETs及其标志物水平在白塞病患者中升高,并参与促凝状态。
- 靶向NETs可能成为降低或预防BD相关血栓风险的治疗靶点。
研究设计与样本
- 研究收集符合国际研究组标准(International Study Group Criteria)的BD患者和健康供者(HD)血样。
- 检测血清或纯化中性粒细胞中的NET组分,包括游离DNA(cfDNA)和髓过氧化物酶(MPO)。
- 比较活动期BD、非活动期BD和HD,以及BD伴血管受累与无血管症状者。
- 评估BD血浆凝血酶生成,并分析其与MPO-DNA复合物和cfDNA的相关性。
- 使用DNAse处理BD血浆和HD血浆,观察凝血酶生成变化,并检查BD活检组织中NETs产生。
主要发现
- 活动期BD患者血清cfDNA水平和MPO-DNA复合物高于非活动期BD患者和HD。
- BD伴血管受累者的cfDNA和MPO-DNA复合物水平显著高于无血管症状者。
- BD患者纯化中性粒细胞较HD表现出自发NETosis。
- BD血浆凝血酶生成显著增加,并与MPO-DNA复合物和cfDNA水平正相关。
- DNAse处理显著降低BD血浆凝血酶生成,但对HD血浆无显著影响。
关键数值与推荐
- BD诊断依据国际研究组标准(International Study Group Criteria for Behçet's disease)。
- 活动期BD患者血清cfDNA和MPO-DNA复合物较非活动期BD和HD升高。
- BD伴血管受累者cfDNA和MPO-DNA复合物显著高于无血管症状者。
- BD血浆凝血酶生成显著增加且与MPO-DNA复合物和cfDNA正相关。
- DNAse处理显著降低BD血浆凝血酶生成,但不降低HD血浆凝血酶生成。
临床怎么用
- 对BD患者,尤其伴血管受累者,可关注NETs标志物(cfDNA、MPO-DNA复合物)作为促凝状态参考。
- NETs参与BD血栓风险,靶向NETs可能为降低或预防BD相关血栓提供治疗方向。
- DNAse处理可降低BD血浆凝血酶生成,提示干预NETs可能改善促凝状态。
局限性
- 摘要未报告样本量、具体数值、P值或置信区间。
- 摘要未说明研究设计类型(如横断面、病例对照)及统计方法细节。
- 摘要未报告NETs靶向治疗在BD患者中的临床干预数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Behçet's disease (BD) is a chronic systemic vasculitis. Thrombosis is a frequent and life-threatening complication. The pathogenesis of BD is poorly understood and evidence supporting a role for primed neutrophils in BD-associated thrombotic risk is scant. To respond to inflammatory insults, neutrophils release web-like structures, known as neutrophil extracellular traps (NETs), which are prothrombotic. We evaluated the role of NETs and markers of NETs in BD. METHODS: Blood samples were collected from patients with BD, according to the International Study Group Criteria for Behçet's disease, and healthy donors (HD). NET components, including cell-free DNA (CfDNA) and neutrophil enzymes myeloperoxidase (MPO), were assessed in serum or in purified neutrophils from patients with BD and HD. RESULTS: Patients with active BD had elevated serum cfDNA levels and MPO-DNA complexes compared with patients with inactive BD and to HD. In addition, levels of cfDNA and MPO-DNA complexes were significantly higher in patients with BD with vascular involvement compared with those without vascular symptoms. Purified neutrophils from patients with BD exhibited spontaneous NETosis compared with HD. Thrombin generation in BD plasma was significantly increased and positively correlated with the levels of MPO-DNA complexes and cfDNA. Importantly, DNAse treatment significantly decreased thrombin generation in BD plasma but not in HD plasma. In addition, biopsy materials obtained from patients with BD showed NETs production in areas of vasculitic inflammation and thrombosis. CONCLUSIONS: Our data show that NETs and markers of NETS levels are elevated in patients with BD and contribute to the procoagulant state. Targeting NETs may represent a potential therapeutic target for the reduction or prevention of BD-associated thrombotic risk.
引用
- Le Joncour A, Martos R, Loyau S, et al. Critical role of neutrophil extracellular traps (NETs) in patients with Behcet's disease. Ann Rheum Dis. 2019. PMID: 31147357. doi:10.1136/annrheumdis-2018-214335
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。